Clinical Trial Update: Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ketoanalogues to prevent muscle mass loss in nephrotic syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Snippet

Sponsor: Military Institute od Medicine National Research Institute | Conditions: Nephrotic Syndrome | Phase 3 | Status: RECRUITING